Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007340
Chunk: 107

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 107
---
 as of the trading day immediately preceding the date this registration
statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and
all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants.

Under the terms of the warrants,
a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its
affiliates and attribution parties, to beneficially own a number of Ordinary Shares which would exceed 4.99% or 9.99%, as applicable,
of our then outstanding Ordinary Shares following such exercise, excluding for purposes of such determination Ordinary Shares issuable
upon exercise of such warrants which have not been exercised. The beneficial ownership limitation may be increased or decreased, provided
that in no event shall it exceed 9.99%, upon notice to us, provided that any increase in the beneficial ownership limitation shall not
be effective until 61 days following the receipt of such notice by us. The number of shares in the table below does not reflect this limitation.
See “Plan of Distribution.” The selling shareholders may sell all, some or none of their Ordinary Shares in this offering.
See “Plan of Distribution.”

| Name of Selling Shareholder                    |     | Number of Ordinary 
 Shares Owned Prior 
 to                 
 Offering **        |               |     | Maximum Number of 
 Ordinary          
 Shares to         
 be Sold           
 Pursuant to this  
 Prospectus **     |             |     | Number of          
 Ordinary           
 Shares Owned After 
 Offering** (1)     |               |     | Percentage 
 of         
 Ordinary   
 Shares     
 Owned      
 after the  
 Offering** 
 *          |     |   |
| Bigger Capital Fund, LP (2)                    |     |                    |   843,460,000 |     |                   | 324,740,000 |     |                    |   518,720,000 |     |            | 2.0 | % |
| Boothbay Absolute Return Strategies, LP (3)    |     |                    |   173,100,000 |     |                   | 169,900,000 |     |                    |     3,200,000 |     |            |   * |   |
| Boothbay Diversified Alpha Master Fund LP (4)  |     |                    |    88,210,000 |     |                   |  86,580,000 |     |                    |     1